Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Enclosed herewith are the details of appointment of M/s Deloitte Haskins & Sells LLP, Chartered Accountants as the Statutory Auditors of the Company. Alkem Laboratories Ltd - 539523 - Corporate Action-Board approves Dividend
The BOD at its meeting held today 29.5.24 has recommended final dividend of Rs. 5 per equity share of Rs. 2 each for FY 31st march 24 for approval of shareholders in the ensuing AGM Alkem Laboratories Ltd - 539523 - Results Financial For Quarter And Year Ended 31St March 24
Pl. find enclosed Audited Financial results for quarter and year ended 31st march 24 Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Directorate
Enclosed herewith are the details of the re-appointment of certain Directors of the Company. Alkem Laboratories Ltd - 539523 - Board Meeting Outcome for Outcome Of Board Meeting Dated 29/05/2024
Please find enclosed herewith the outcome of the Board meeting dated 29th May, 2024 Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q4FY24 and FY24 financial results will be held on Wednesday, 29th May, 2024 at 05.00 p.m. Please find attached herewith the conference call details. Alkem Laboratories Ltd - 539523 - Board Meeting Intimation for Notice Of Meeting Of Board Of Directors Of The Company Scheduled To Be Held On 29Th May, 2024.
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 ,inter alia, to consider and approve Alkem Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024, inter alia, to consider and approve (i) the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2024; and (ii) to consider and recommend Final Dividend, if any, for financial year ended 31st March, 2024. Kindly take note of the same. Alkem Laboratories Ltd - 539523 - Intimation Under Regulation 30 Of SEBI LODR - Regulatory Order
Pursuant to Regulation 30 of SEBI LODR, this is to inform you that the Company has received an order passed by the statutory authority under the Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith. Alkem Laboratories Ltd - 539523 - Intimation Under Regulation 30 Of SEBI LODR - Regulatory Order
Pursuant to Regulation 30 of SEBI LODR, this is to inform you that the Company has received an order passed by the statutory authority under the Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.